Pleiotropic effects of cytokines on left ventricular remodelling and cardiovascular stem cell therapy W. Wojakowski, MD, FESC Silesian School of Medicine,

Slides:



Advertisements
Similar presentations
STEM-AMI OUTCOME TRIAL STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial   A national, multicentre, randomised, open-label, Phase.
Advertisements

Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Department of Cardiovascular Medicine John Radcliffe Hospital, Oxford
Notch and Cancer IPO-LISBOA CIPM Angiogenesis group Francisco Caiado Sérgio Dias.
Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial Presented.
GENERATION OF CELLS OF THE IMMUNE SYSTEM STEM CELLS.
Angelo Avogaro Università degli Studi di Padova La carenza di cellule endoteliali progenitrici: un passaggio chiave nell’ambito della patologia cardiovascolare.
Bone Marrow Stem Cells in Cardiac Repair. 2 Dimmeler S et al. Arterioscler Thromb Vasc Biol. 2007;Oct. 19 epub. EC differentiation SMC differentiation.
prognosis of patients with Acute Myocardial Infarction remains dismal.
M. Valgimigli University of Ferrara Italy Autologous bone marrow stem cell mobilization Induced by G-CSF after MI Autologous bone marrow stem cell mobilization.
Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Stem cell therapy in cardiac practice
Stem cell therapy: what a cardiologist needs to know Robert Roberts MD Chief of Cardiology Baylor College of Medicine Houston, Texas Piero Anversa MD Director,
Heartline Trial sulla terapia cellulare:
Mesenchymal Stem/Progenitor cells for Therapeutic and Tissue engineering applications Yu-Hui Tsai, Ph.D. ( Daniel Tzu-bi Shih) Grad. Inst. Medical Sciences.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Connexin-43 regulates the cell cycle entry of HSC and the migration of progenitors towards and from BM Daniel Gonzalez-Nieto, PhD.
MIPS Molecular Imaging Program at Stanford School of Medicine Department of Radiology Stem Cell Therapy & Cardiovascular Molecular Imaging Joseph Wu, MD,
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood Authors: Source:
Endothelial Progenitor Cells (EPCs)
Role of gp130 Activation for HSC Self-renewal Aurore Degrange and Lisa Treat BE.400 Term Project December 10, 2002.
Cell Therapy in CV Disease: Future Directions. 2 Anversa P, Nadal-Ginard B et al. Nature. 2002;415: Cardiac renewal: Is the goal in sight? “Remaining.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Stem Cell Identification Nozad H. Stem cell workshop Stem cell Research center Tabriz medical university In The Name of God.
HOMING Ewing vs Paget Trapping vs homing (controlled arrest) “Seed and soil” Organ-specific metastatic colonization of favorable microenvironment.
Safety and effectiveness of granulocyte-colony stimulating factor in advanced chronic heart failure Jacob Joseph, MD Veterans Affairs Healthcare System-
Directed differentiation allows production of a desired cell type
Jay H Traverse, MD Principal Investigator, LateTIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Regeneration and stem cells Definition 1) Self-renewing capability  Clonal expansion 2) Differentiation into various types of cells, multipotent = self.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sonic Hedgehog-Induced Functional Recovery After.
IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.
Electrical Muscle Stimulation Induces an Increase of VEGFR2 on Circulating Hematopoietic Stem Cells in Patients With Diabetes  Asa Hidmark, PhD, Ioannis.
By Justin Klee and Lucy Schultz
The TIME Randomized Trial:
Cell Repair Therapy – Phase 1 Lessons Learned – Clinical Studies
The NHLBI TIME Trial: Role of Microvascular Obstruction in 2-Year Clinical and MRI Follow-up Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis.
Endothelial Progenitor Cells and Development of Collateral Formation in Patients with Chronic Total Coronary Artery Occlusion and Transplantation of EPCs.
Cardiac Regeneration & Stem Cells in 2005
Tauroursodeocycholic acid, bile acid, induces blood vessel repair
Westerweel PE et al. Eur Heart J 2008;29:
Intravenously Delivered Mesenchymal Stem Cells:
Cell Therapy 2014 Las Vegas, NV, USA
The pathophysiology of myocardial infarction-induced heart failure
Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal.
by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I
In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy  Yan Zhang, MD, MSc, Serena.
Cardiac Cell Repair Therapy: A Clinical Perspective
Downregulation of the CXC chemokine receptor 4/stromal cell–derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and.
HOMING
Volume 5, Issue 5, Pages (November 2015)
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34- positive endothelial cells in a hindlimb ischemia model: Implications for.
Pravastatin Improves Remodeling and Cardiac Function After Myocardial Infarction by an Antiinflammatory Mechanism Rather than by the Induction of Angiogenesis 
Volume 23, Issue 2, Pages (June 2016)
CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair  N.
Volume 109, Issue 5, Pages (May 2002)
EMERGING ROLE OF STEM CELLS In CARDIOVASCULAR THERAPY
Volume 23, Issue 12, Pages (December 2015)
Volume 4, Issue 4, Pages (April 2009)
Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model  Yasuhiro.
Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation  Shinji Tomita, MD, PhD, Donald.
Process and mechanisms of blood vessel formation.
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
Volume 12, Issue 6, Pages (December 2005)
Eduardo Marbán, MD, PhD  Mayo Clinic Proceedings 
Volume 21, Issue 3, Pages (March 2013)
Proposed mechanisms for fibrointimal proliferation in pulmonary tumour thrombotic microangiopathy (PTTM). Proposed mechanisms for fibrointimal proliferation.
Zhi Cui, MSc, Ren-Ke Li, MD, PhD 
Volume 26, Issue 7, Pages (July 2018)
Presentation transcript:

Pleiotropic effects of cytokines on left ventricular remodelling and cardiovascular stem cell therapy W. Wojakowski, MD, FESC Silesian School of Medicine, Katowice, Poland

Financial disclousure:  Supported by the grants from Polish Ministry of Science and Higher Education, Servier Research Grant and European Vascular Genomics Network (EVGN)  No conflict of interest

HEMATOPOIETIC AND INFLAMMATORY CYTOKINES  MOBILIZATION OF BONE MARROW-DERIVED  CARDIOGENIC DIFFERENTIATION OF BM- DERIVED CELLS,  DIRECT EFFECTS ON CARDIOMYOCYTES,  MARKERS OF MYOCARDIAL INJURY,  NON-SPECIFIC MARKERS OF TISSUE INJURY

* p< vs. CTRL ** p<0.003 vs. CTRL *** p=ns vs. CTRL * *** * ** * p<0.05 vs. baseline ** p< vs. baseline *** p=ns vs. baseline *** * ** Wojakowski, Circulation 2004;110:3213 Massa, Blood 2005,105:199 Mieno, Circulation 2006;114:186

Wojakowski, Circulation 2004;110:3213

CD34/CXCR4 + [cells/µL] p<0.03 p<0.01 p<0.03 SDF-1 [pg/mL]

Leone et al. Eur Heart J 2005; 26 Correlation between CD34+ cells and LV function at 1 year follow-up

Baseline CD34/CXCR4+ cells:  negatively correlated with LV remodeling: LVEDV (r=-0.31; p<0.03), LVESV (r=-0.34; p<0.04). Baseline CD34/CXCR4+ cells:  negatively correlated with the mean delayed enhancement after 1 year (r=-0.30; p<0.03)  number of segments displaying impaired stress first pass perfusion (r=-0.57; p<0.05) 1-YEAR FOLLOW-UP BY cMRI Wojakowski, AHA 2006

1-YEAR FOLLOW-UP (cMRI) CD34/CXCR4+; R=0.48, p=0.004 CD34/CXCR4+; R=0.51, p=0.002 ACUTE FOLLOW-UP Wojakowski, AHA 2006 Baseline and 12 month SDF-1 levels:  no correlations with LVEF, LV remodeling,  myocardial perfusion  no correlation with cardiopulmonary exercise test

SDF-1 IN PERIINFARCT MYOCYTES AND VESSELSREMOTE MYOCARDIUM Abbott, Circulation 2004,110:3300 Kucia, M. et al. Circ Res 2004;95:1191

Kucia, Circ Res 2004;95:1190 BMMNC chemoattracted to the infarcted myocardium in SDF-1-, HGF- and LIF-dependent manner

Kucia, Circ Res 2004;95:1191

CXCR4 C-Met LIF-R SDF-1 HGF LIF gradient Peripheral Blood Bone Marrow Skeletal Muscle Other Tissues Myocardium Brain Very Small TCSC Number Low Expression of Cardiac/Endothelial Markers Ratajczak, Biol Cell 2005, 97, Wojakowski, Heart 2007

CXCR4 c-Met LIF-R SDF-1 HGF LIF gradient Peripheral Blood Bone Marrow Skeletal Muscle Other Tissues Infarcted Myocardium Increased Number Increased Expression of Cardiac/Endothelial Markers Mobilization Homing/Engraftment Ratajczak, Biol Cell 2005, 97, Wojakowski, Heart 2007

BONE MARROW ASPIRATE ( mL) BMCells TREATMENT NON-SELECTED BM MNC CONTROL STEMI + LVEF≤40% (PRIMARY PCI <12 hrs.) randomization MRI, LV-ANGIO, ECHO, CONTRAST ECHO, CARDIOPULMONARY EXERCISE TEST CD34/CXCR4+ CELLS 6 MO. MRI, LV-ANGIO, ECHO, CONTRAST ECHO, CARDIOPULMONARY EXERCISE TEST IMMUNOMAGNETIC SELECTION 12 MO. ECHO, CLINICAL F-U REGENT TRIAL NCT

IT SEEMS THAT SDF-1 ATTRACTS LOTS OF INTERESTING THINGS… CXCR4

Medium aloneSDF-1 Chemotaxis to SDF-1 FACS SORTER CD45 - CD45 + Bone Marrow Mononuclear Cells CXCR4 + CD45 - CXCR4 + CD45 +

Which cells are attracted by SDF-1 ? Biol Cell 2005, 97,

FSC SSC Sca-1 PE-Cy5 Lineage PE CD45 APC-Cy7 Counts 50.5% 0.16% 0.009% 0.15% Sca-1 + lin - CD45 + Sca-1 + lin - CD45 -

Sca-1 + lin - CD45 + Sca-1 + lin - CD45 - Leukemia 2006,20: Very Small Embryonic Like (VSEL) Stem Cell Hematopoietic Stem Cell

RQ-PCR analysis in Sca-1 + lin - CD45 - cells TCSC markersSca-1 + lin - CD45 + Sca-1 + lin - CD45 - cardiac Nsx2.5/Csx 2.05 ± ± 7.93 * GATA ± ± * endothelium VE-cadherin 1.05 ± ± * Leukemia 2006,20:

unpurified BMMNC Sca-1 + lin - CD45 + Sca-1 + lin - CD45 - Leukemia 2006,20: Oct4 SSEA-1 Nanog AP staining on ES-D3 cell-derived embryonic bodies AP staining on VSEL derived embryonic like bodies

Leukemia 2006, 20,  myosin heavy chain troponin I Kucia, Circ Res 2004;95:1190

Genes down-regulated in VSELs vs. differentiation series:  ION CHANNELS (K+, Ca2+), CONNEXINS  LIFR, c-kit, c-met  CELL MOTILITY,  FIBRONECTIN RECEPTOR COMPLEX,  CARDIAC AND VESSEL DEVELOPMENT Genes with higher expressionin VSELs vs. differentiation series:  CXCR4,  TGFβ SIGNALLING Transcriptional profile of VSEL-derived cardiomyocytes Wojakowski, ACC 2007

Mobilization of HSC and VSEL into peripheral blood after AMI Control Sham control 24h 48h7 days AB Control Sham control 24h 48h7 days * # * # * # * # * vs. control # vs. sham control P < 0.05 Courtesy of MZ Ratajczak

CONTROL 0,08 0,05 0,12 Wojakowski, Circulation 2004;110:3213 STEMI 0,21 0,06 0,32 Massa, Blood 2005,105:199

Fazel, J. Clin. Invest. 2006;116:1865

 SDF-1 / CXCR4  HGF / c-met  SCF / c-kit  LIF / LIFR  VEGF / VEGFR  G-CSF / G-CSFR  GM-CSF / GM-CSFR  M-CSF / M-CSFR  flt3 – FL  Epo - EpoR

G-CSF induced mobilization G-CSF G-CSF and HSC:  proliferation,  differentiation,  survival  G-CSF and non-HSC: cardiomyocytes,  endothelial cells,  neuronal cells

STEMMI Ripa et al.: Circulation 2006,113 Regional systolic wall thickening GCSF vs. placebo, p=NS MRI GCSF vs. placebo, p=NS REVIVAL-2 Zohlnhofer et al.: JAMA 2006,295,1003

Britten, Circulation 2003;108:2212 Migratory capacity of transplanted progenitor cells and infarct remodeling

Honold, ATVB 2006;26: Migratory activity of nonmobilized and G-CSF-mobilized EPC

CELL MOBILIZATION FOR IMPROVEMENT OF LV FUNCTION  IMPROVED CONTRACTILITY IN AREAS REMOTE FROM THE INFARCT AREA  MYOCARDIAL REGENERATION AND PROLIFERATION CONFINED TO INFARCTED AREA  RESPONSIVENESS OF BONE MARROW CELLS TO CHEMOATTRACTANTS DECLINES IN AGE-DEPENDENT FASHION  STANDAD MOBILIZATION AGENTS (G-CSF) IMPAIR THE RESPONSIVENES OF PROGENITOR CELLS TO PIVOTAL CHEMOATTRACTANTS

Dawn, B. et al. Circ Res 2006;98:1098 Combination of cytokines in murine model of reperfused MI G-CSF G-CSF + FL (flt3 ligand) G-CSF+SCF

Dawn, B. et al. Circ Res 2006;98:1098 lin-/Sca-1+/c-kit+ cells from untreated bone marrow and peripheral blood

 improved mobilization  qualitative differences in function of mobilized cells (adhesion molecules)  higher rate of cardiomyocyte proliferation  better LV lunction, reduced remodeling COMBINATION OF CYTOKINES

UPREGULATION OF SDF-1 A BC Leukemia 2004, 18: SDF-1 D Aicher, Circulation 2006;114:2823

 MOBILIZATION OF BM-DERIVED PROGENITORS - INCREASED EXTRAVASATION, HOMING - INCREASED EXPRSSION OF ADHESION MOLECULES  TRANSDIFFERENTIATION INTO CARDIOMYOCYTES(?)  MIGRATION AND PROLIFERATION OF RESIDENT CARDIAC STEM CELLS  PARACRINE EFFECTS OF THE RECRUITED CELLS - ANTIAPOPTOTIC EFFECT - FAVOURABLE CHANGES IN ECM - INCREASED ANGIOGENESIS HEMATOPOIETIC CYTOKINES

LOUISVILLE Mariusz Z. Ratajczak Magdalena Kucia Janina Ratajczak Ewa Zuba-Surma Ryan Reca KATOWICE Michał Tendera Paweł Buszman Marek Król Kasia Maślankiewicz Andrzej Pyrlik Radek Parma Rafał Wyderka Joanna Ciosek Sebastian Dworowy Iwona Mróz SZCZECIN Bogdan Machaliński, Maciek Halasa KRAKÓW Marcin Majka Ania Zebzda BRISTOL Paolo Madeddu Nicole Kraenkel Constanza Emanueli

GOOD THING ABOUT BEING INTERVENTIONAL CARDIOLOGIST IS TO GET A LOT OF EXPERIENCE IN HEMATOLOGY THANK YOU